Cargando…
A retrospective cohort study of Libmeldy (atidarsagene autotemcel) for MLD: What we have accomplished and what opportunities lie ahead
Metachromatic leukodystrophy (MLD) results from ARSA gene mutations. Affected individuals meet early milestones before neurological deterioration and early death. Atidarsagene autotemcel (arsa‐cel), an autologous haematopoietic stem cell gene therapy (HSC‐GT) product, has demonstrated sustained clin...
Autores principales: | Horgan, Claire, Watts, Kelly, Ram, Dipak, Rust, Stewart, Hutton, Rebekah, Jones, Simon, Wynn, Rob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10494509/ https://www.ncbi.nlm.nih.gov/pubmed/37701322 http://dx.doi.org/10.1002/jmd2.12378 |
Ejemplares similares
-
A systematic review of clinical effectiveness and safety for historical and current treatment options for metachromatic leukodystrophy in children, including atidarsagene autotemcel
por: Armstrong, Nigel, et al.
Publicado: (2023) -
The Search for Resistance to Cassava Mosaic Geminiviruses: How Much We Have Accomplished, and What Lies Ahead
por: Fondong, Vincent N.
Publicado: (2017) -
Disease encumber-What lies ahead??
por: Damle, S. G.
Publicado: (2015) -
Looking back and what lies ahead
por: Chang, David
Publicado: (2022) -
RESEARCH INITIATIVES: What Lies Ahead for Nanotechnology?
por: Stemp-Morlock, Graeme
Publicado: (2009)